Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
Article
Ocean, AJ, Pennington, KL, Guarino, MJ et al. (2012). Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
. CANCER, 118(22), 5497-5506. 10.1002/cncr.27592
Ocean, AJ, Pennington, KL, Guarino, MJ et al. (2012). Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial
. CANCER, 118(22), 5497-5506. 10.1002/cncr.27592